← Evidence map

ArticleHealth services insights2026

Most-Favored-Nation Benchmarking Versus Value-Based Contracting: Institutional Fit of Pharmaceutical Pricing Tools in the United States, Canada, and the United Kingdom.

Kola Adegoke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Most-Favored-Nation Benchmarking Versus Value-Based Contracting: Institutional Fit of Pharmaceutical Pricing Tools in the United States, Canada, and the United Kingdom. | OpenQuestion